Track the 한미약품 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 한미약품 has published 118 insider filings. Market capitalisation: €4,368.3bn. The latest transaction was filed on 2 July 2026 (Mixed). Among the most active insiders: 국민연금공단. The full history is accessible without an account.
117
Insider Decl.
n/a
Thresholds
n/a
63 ops.
Buy Volume
n/a
18 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 한미약품 Strong Buy (bullish), based on 12 analysts. Average price target: ₩599,167.
17Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,288 of 28,169 companies
58.3
score / 100
Value
45
Quality
71
FCF yld1.9%
Earn yld3.4%
EV/EBITDA16.4x
ROE14%
Gross mgn57%
Net mgn11%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.